Algernon Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The report of Algernon Pharmaceuticals Inc employs information from across the internet as well as from available disclosures by Algernon Pharmaceuticals Inc. The dashboard includes a Q&A table on Algernon Pharmaceuticals Inc. This page is a zero-cost ESG analysis covering Algernon Pharmaceuticals Inc.
Algernon Pharmaceuticals Inc in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 5.3 and governance score of 8.0.
7.1
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Analytik Jena AG | 8.0 | High |
| 1 | Amniotics AB (publ) | 8.0 | High |
| 23 | Gilead Palo Alto Inc | 7.5 | High |
| 23 | ViroGates A/S | 7.5 | High |
| 25 | Algernon Pharmaceuticals Inc | 7.1 | High |
| 25 | Cereno Scientific AB | 7.1 | High |
| 25 | Dancann Pharma A/S | 7.1 | High |
| ... | ... | ... | |
| 182 | Wesana Health Holdings Inc | 0.0 | Low |
| 182 | rEVO Biologics Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Algernon Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Algernon Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Algernon Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Algernon Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Algernon Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Algernon Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Algernon Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non"alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets NMDA-type subunit 2B (Glu2NB), as well as exhibits agonist activity for the Sigma-1 receptor, a chaperone protein up-regulated during endoplasmic reticulum stress. It is also developing AP-188, a psychedelic compound that is part of the tryptamine family for the treatment of ischemic stroke in humans. Algernon Pharmaceuticals Inc. has an agreement with Charles River Laboratories for preclinical studies of AP-188 for the company's stroke clinical research program. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.